Imagine
The potential of medical innovation is limitless. If Europe fully seizes this opportunity, just imagine what we could achieve
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA is asking EU leaders to work together with industry to create opportunities to, once again, make the region a world-leader in life sciences
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Blog articles 21.05.25
Cross-border trials: ‘Not every patient is as lucky as me’
Patient story: travelling to Germany for a clinical trial offered Savo Pilipovic access to life-saving melanoma therapy. But his story is the exception,...
Read Article -
Blog articles 20.05.25
Clinical trials: Good for patients, good for Europe (Guest blog)
The EU Biotech Act is a unique opportunity to strengthen Europe’s clinical research ecosystem and regain global competitiveness in life sciences. We present...
Read Article -
Statements & press releases 14.05.25
Almost 100 new medicine approvals tracked; new data gives clearest picture yet of delays for patients ...
EFPIA also publishes first report aimed specifically as a catalyst for action to tackle inequalities faced by smaller countries.
Read Article -
Partner Event 23.06.25
IHI Call Days - call 11
The IHI Call Days for IHI call 11 will take place from 23 to 30 June 2025 online and will include sessions on the individual topics as well as the rules...
View Event -
Partner Event 24.06.25
EU-X-CT Public Stakeholder Conference: Final recommendations launch
Borders should no longer be barriers in clinical trials.
View Event -
External Event 06.10.25
Biotech Business Mission to Japan 2025 - Call for applications
Join the biotech business mission in Japan from 6-10 October 2025, organised by the EU-Japan Centre for Industrial Cooperation. Only 12 participants will...
View Event
Featured Articles
